Introduction Thyroid cancer (TC) is an important common endocrine malignancy, and its
incidence has increased in the past decades. The current TC diagnosis and classification …

Arsenic Trioxide is an old drug that has recently re-introduced into new medicine. It is very
potent against a specific type of leukemic cells harboring translocation between …

Purpose We examined the outcome of patients with newly diagnosed acute promyelocytic
leukemia (APL) treated with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) with or …

Oncometabolites: A new insight for oncology Page 1 Mol Genet Genomic Med. 2019;7:e873. |
1 of 3 https://doi.org/10.1002/mgg3.873 wileyonlinelibrary.com/journal/mgg3 DOI: 10.1002/mgg3.873 …

Current treatment for acute promyelocytic leukemia (APL) usually includes an induction
phase with all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy, followed …

Thyroid cancer, one of the most widespread malignancies of the endocrine-related system
that over the past three decades, has a vivid increasing rate. The diagnosis and …

Introduction Renal cell cancer (RCC) syndrome is linked to Krebs cycle compartments and
their coding genes' alterations like succinate dehydrogenase genes (SDHx). Here we …

Platinum drugs (cisplatin, oxaliplatin, and carboplatin) and arsenic trioxide are the only
commercial inorganic non-radioactive anticancer drugs approved by the US Food and Drug …

Thyroid cancer is one of the most common endocrine malignancies, with increasing
incidence all over the world. In spite of good prognosis for differentiated thyroid carcinoma …

Circulating cell‐free DNA (cfDNA) has been considered as a diagnostic source to track
genetic and epigenetic alterations in cancer. We aimed to study mutation in addition to the …